63 related articles for article (PubMed ID: 16713745)
1. Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?
Noh KW; Pungpapong S; Wallace MB; Woodward TA; Raimondo M
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):782-9. PubMed ID: 16713745
[TBL] [Abstract][Full Text] [Related]
2. Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
Groza Y; Lacina L; Kuchař M; Rašková Kafková L; Zachová K; Janoušková O; Osička R; Černý J; Petroková H; Mierzwicka JM; Panova N; Kosztyu P; Sloupenská K; Malý J; Škarda J; Raška M; Smetana K; Malý P
Cell Commun Signal; 2024 May; 22(1):261. PubMed ID: 38715108
[TBL] [Abstract][Full Text] [Related]
3. The role of IL-6/JAK2/STAT3 signaling pathway in cancers.
Huang B; Lang X; Li X
Front Oncol; 2022; 12():1023177. PubMed ID: 36591515
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of Chronic Pancreatitis: A systematic literature review.
Cruz-Monserrate Z; Gumpper K; Pita V; Hart PA; Forsmark C; Whitcomb DC; Yadav D; Waldron RT; Pandol S; Steen H; Anani V; Kanwar N; Vege SS; Appana S; Li L; Serrano J; Rinaudo JAS; Topazian M; Conwell DL;
Pancreatology; 2021 Mar; 21(2):323-333. PubMed ID: 33558189
[TBL] [Abstract][Full Text] [Related]
6. Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Recurrent Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Lowe ME; Goodman MT; Coté GA; Glesby MJ; Haupt M; Schork NJ; Singh VK; Andersen DK; Pandol SJ; Uc A; Whitcomb DC
Pancreas; 2018; 47(10):1193-1199. PubMed ID: 30325857
[TBL] [Abstract][Full Text] [Related]
7. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas.
Tulla KA; Maker AV
Langenbecks Arch Surg; 2018 Mar; 403(2):151-194. PubMed ID: 29218397
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations.
Suenaga M; Dudley B; Karloski E; Borges M; Irene Canto M; Brand RE; Goggins M
Pancreas; 2018 Jan; 47(1):35-39. PubMed ID: 29200129
[TBL] [Abstract][Full Text] [Related]
9. Local and Systemic Expression of Immunomodulatory Factors in Chronic Pancreatitis.
Komar HM; Hart PA; Cruz-Monserrate Z; Conwell DL; Lesinski GB
Pancreas; 2017 Sep; 46(8):986-993. PubMed ID: 28796136
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic Pancreas Fluid Collection: Methods and Relevance for Clinical Care and Translational Science.
Hart PA; Topazian M; Raimondo M; Cruz-Monserrate Z; Fisher WE; Lesinski GB; Steen H; Conwell DL
Am J Gastroenterol; 2016 Sep; 111(9):1258-66. PubMed ID: 27481304
[TBL] [Abstract][Full Text] [Related]
11. Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.
Yako YY; Kruger D; Smith M; Brand M
PLoS One; 2016; 11(5):e0154016. PubMed ID: 27170998
[TBL] [Abstract][Full Text] [Related]
12. Role of emerging molecular markers in pancreatic cyst fluid.
Al-Haddad M
Endosc Ultrasound; 2015; 4(4):276-83. PubMed ID: 26643693
[TBL] [Abstract][Full Text] [Related]
13. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
[TBL] [Abstract][Full Text] [Related]
14. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
Maker AV; Carrara S; Jamieson NB; Pelaez-Luna M; Lennon AM; Dal Molin M; Scarpa A; Frulloni L; Brugge WR
J Am Coll Surg; 2015 Feb; 220(2):243-53. PubMed ID: 25592469
[No Abstract] [Full Text] [Related]
15. Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.
Liou GY; Döppler H; Necela B; Edenfield B; Zhang L; Dawson DW; Storz P
Cancer Discov; 2015 Jan; 5(1):52-63. PubMed ID: 25361845
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.
Wang J; Raimondo M; Guha S; Chen J; Diao L; Dong X; Wallace MB; Killary AM; Frazier ML; Woodward TA; Wang J; Sen S
J Cancer; 2014; 5(8):696-705. PubMed ID: 25258651
[TBL] [Abstract][Full Text] [Related]
17. Nuclear receptors and pathogenesis of pancreatic cancer.
Polvani S; Tarocchi M; Tempesti S; Galli A
World J Gastroenterol; 2014 Sep; 20(34):12062-81. PubMed ID: 25232244
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.
Kanda T; Jiang X; Yokosuka O
World J Gastroenterol; 2014 Jul; 20(28):9229-36. PubMed ID: 25071315
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profiles in patients receiving antioxidant therapy within the ANTICIPATE trial.
Shah N; Siriwardena AK
World J Gastroenterol; 2013 Jul; 19(25):4001-6. PubMed ID: 23840145
[TBL] [Abstract][Full Text] [Related]
20. CXCR2: a target for pancreatic cancer treatment?
Hertzer KM; Donald GW; Hines OJ
Expert Opin Ther Targets; 2013 Jun; 17(6):667-80. PubMed ID: 23425074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
